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The progress of science is punctuated by the advent of revolutionary technologies 
that provide new ways and scales to formulate scientific questions and advance 
knowledge. Following on from electron microscopy, cell culture and PCR, next-
generation sequencing is one of these methodologies that is now changing the way 
that we understand viruses, particularly in the areas of genome sequencing, 
evolution, ecology, discovery and transcriptomics. Possibilities for these 
methodologies are only limited by our scientific imagination and, to some extent, by 
their cost, which has restricted their use to relatively small numbers of samples. 
Challenges remain, including the storage and analysis of the large amounts of data 
generated. As the chemistries employed mature, costs will decrease. In addition, 
improved methods for analysis will become available, opening yet further 
applications in virology including routine diagnostic work on individuals, and new 
understanding of the interaction between viral and host transcriptomes. An exciting 
era of viral exploration has begun, and will set us new challenges to understand the 
role of newly discovered viral diversity in both disease and health. 
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Introduction 
We need only to look at the size and growth of international nucleotide databases to 
realize the importance of sequencing to science in general, and virology in particular. In 
the latest published release of GenBank (#179; August 2010), there were some 970 million 
and 43 million bases of viral and phage origin respectively, representing an annual growth 
of 20–24% (Fig. 1a) (Benson et al., 2011), a growth rate comfortably above average for 
the database as a whole. The sequencing effort is being driven almost entirely by human 
clinical significance, with 17 of the top 20 sequenced viruses causing disease in humans 
(Fig. 1b). In its entirety, this sequencing effort represents a significant achievement; the 
information generated has wide-ranging impact on all areas of virology, from diagnosis to 
pathogenesis, and from vaccine design to viral evolution and ecology. 
All of this output has only been possible through embracing what were, at their outset, two 
groundbreaking and revolutionary methodologies. These allowed those interested in 
understanding viruses first to amplify and then to sequence viral nucleic acids, namely 
DNA amplification by PCR (Mullis et al., 1986) and DNA sequencing with chain-terminating 
inhibitors (Sanger sequencing or first-generation sequencing) (Sanger et al., 1977). Using 
these technologies, even a fairly basic laboratory could amplify and generate 100–1000 
bases of sequence relatively easily in a single day, and by applying first-generation 
sequencing technology on a large scale in highly specialized sequencing centres, the first 
large high-profile genomes were published, notably those for Homo sapiens, Plasmodium 
falciparum and Mycobacterium tuberculosis (Cole et al., 1998; Gardner et al., 2002; 
Lander et al., 2001). The main limitations to the use of these technologies are restricted 
scalability, their cost when applied to large genomes and their frequent reliance on prior 
and specific template amplification by PCR or in bacterial clones. As such, genome 
projects were largely restricted to high-profile organisms, model organisms and human 
pathogens. 
With these limitations in mind, new methods of sequencing have now been developed 
(second-generation or, more commonly, next-generation sequencing; NGS) that have 
entirely revolutionized our ability to sequence. Overnight, it is now possible to generate 
many millions of bases of sequence and this has opened many new opportunities, making 
large-scale sequencing projects accessible to us all, whatever our field of biology. In this 
review, we shall give an overview of these methods and look particularly at their increasing 
application in virology, specifically in virus discovery, genome sequencing and 
transcriptomics. 
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Technology 
There are an increasing number of NGS technologies in the marketplace, all using slightly 
different methodologies to achieve clonal amplification and sequencing (Table 1). These 
methodologies are likely to be subject to continual modification, although the basic 
principles will probably remain the same. 
 
Instruments 
 
454 sequencing (Roche Diagnostics). 
dsDNA in solution is first sheared by nebulization (converted into a fine spray) or amplified 
by PCR, and fragments of the appropriate size are selected (Fig. 2). These fragments are 
blunt-ended and dephosphorylated, followed by the ligation of two separate adapters (A 
and B). The B adapter is biotinylated, allowing subsequent purification using streptavidin-
coated beads. Subsequently, denaturation releases from the beads only those molecules 
that contain an A primer on one end and a B primer on the other. These molecules 
constitute the DNA library, which is bound to microbeads through primer hybridization 
under conditions that favour a single molecule per bead (Fig. 3a). Subsequently, an 
emulsion is formed in a water and oil mixture, thus capturing individual beads and 
amplification reagents, including primers, one of which is biotinylated, in their own 
emulsion microreactor (Fig. 3b). Thermal cycling then results in the emulsion-based clonal 
amplification of individual molecules (Fig. 3c). After amplification, the emulsion is disrupted 
and beads coated with amplified products are enriched using streptavidin-coated beads 
and magnetic separation. The amplified products are denatured, bound to a sequencing 
primer and separated into individual wells of a picotitre plate, each well being large enough 
to accommodate a single bead (Fig. 4a). Sequencing then takes place by pyrosequencing, 
whereby each nucleotide incorporation leads to the release of pyrophosphate (PPi) (Fig. 
5b). This is converted via ATP to generate light, the amount of which is proportional to the 
number of bases incorporated. The strength of this system is its read length of 
approximately 500 bases, making it particularly suitable for amplicon sequencing and 
bridging across complex sequences. Its Achilles’ heel is its reliance on pyrosequencing, 
which creates difficulties for sequencing homopolymer runs, leading to an error rate in 
individual reads of 1%, mostly attributable to insertions and deletions (Gilles et al., 2011; 
Wang et al., 2007). Whilst depth of coverage can usually overcome this, it becomes more 
problematic when individual read data are used to assess population diversity (see section 
on targeted amplification). 
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SOLiD sequencing (Life Technologies). 
This methodology starts in a similar way to that described above, with DNA fragmentation 
(Fig. 2), ligation to beads, and emulsion PCR (Fig. 3a–c). Following denaturation of 
amplified products, the beads are attached to a glass slide for sequencing (Fig. 4b). The 
density of beads can be extremely high, and determines the ultimate number of reads 
achieved. Unlike all other methodologies, sequencing occurs by hybridization and ligation 
(Fig. 5f) with fluorescently labelled 8mers, which are of the general sequence 3′-
CTNNNZZZ-5′–label, where N represents a degenerate base, and Z a ‘universal’ modified 
base with no binding preference (Fig. 6). Specificity of ligation and sequencing comes only 
from the 3′ dinucleotides, of which there are clearly 16 combinations. These 16 sequencing 
probes are labelled with one of four dyes, leaving any individual dye associated with four 
primers. Sequencing starts by hybridization of a primer and proceeds by the progressive 
ligation of 8mers, fluorescence detection to identify which sequencing probe pool was 
incorporated, and cleavage to remove the label and three 5′ universal bases. This leaves a 
5mer in place on the newly extended strand, from which the process is repeated. This first 
round of ligation reactions gathers sequence information on positions 1 and 2, 6 and 7, 11 
and 12, etc. This process is then repeated with a starting primer that is displaced by 1 nt in 
the 5′ direction (upstream), allowing sequence information to be gathered on positions 2 
and 3, 7 and 8, 12 and 13, etc. The process is repeated from starting primers displaced 2, 
3 and 4 nt upstream. Independent ligation reactions starting from each of these five 
primers allows the software to recreate the final sequence. It also means that each 
position in the sequence is interrogated twice, leading to high accuracy. 
 
Illumina sequencing. 
Following DNA fragmentation, adapter ligation and gel purification, adapter-ligated, single-
stranded sequences are annealed to a glass plate that is precoated with oligos 
complementary to the adapters (Fig. 3d–h). These oligos serve both to capture the 
template DNA and as primers for subsequent amplification. Amplification occurs on the 
slide by a process termed ‘bridge amplification’, in which each single-stranded molecule 
binds at both ends to the oligo primers on the slide. Successive rounds of PCR result in 
the generation of tiny islands or clusters of amplified molecules (Fig. 3h), which serve as 
clones for subsequent sequencing using chain terminators, similar to traditional Sanger 
sequencing. However, unlike the Sanger method, Illumina uses fluorescently labelled 
reversible terminators, such that each single base incorporation on each molecule 
temporarily terminates the reaction (Fig. 5g). A high-resolution digital image is used to 
determine which nucleotide is incorporated in each DNA clonal cluster. After imaging, the 
terminator is reversed chemically, allowing the template molecule to be extended again in 
the next round of sequencing. As such, the sequencing reaction proceeds to conclusion on 
the majority of molecules. 
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Helicos sequencing (Helicos Biosciences). 
Helicos has been the first true single-molecule sequencing technology to enter the 
marketplace, with no template amplification prior to sequencing. The methodology starts in 
a similar way to those already described, with template fragmentation and adapter ligation 
(Fig. 2). This time, a poly(A) adapter is added to the 3′ end of the single-stranded DNA 
template, finishing with a single fluorescently labelled dATP. This poly(A) tag is used to 
capture each template molecule onto a flow cell using oligo(dT) probes, at a density of 
over 100000000 cm2 (Fig. 4d). A laser locates the bound templates, prior to the cleavage 
of the 3′ fluorescent label. A DNA polymerase and fluorescently labelled, reversible 
terminator nucleotides are then added sequentially, with imaging detecting each 
incorporated base (Fig. 5g). This method has been used to sequence RNA directly without 
prior cDNA synthesis (Ozsolak et al., 2009). 
 
PacBio sequencing (Pacific Biosciences). 
Unlike other NGS technologies, in this method it is the DNA polymerase that is 
immobilized on the floor of a microcell. Fragmented dsDNA is ligated to hairpin adapters to 
create circular DNA (Fig. 3i–m). These are amplified linearly using primers complementary 
to hairpin sequence, and then captured by a single molecule of DNA polymerase and 
sequenced in the bottom of a well (‘Zero Mode Waveguides’) (Fig. 4e). Fluorescently 
labelled nucleotides (one colour for each base) diffuse into the cell from above. Unlike 
other systems, the fluorescent molecule is phospholinked, meaning that it is cleaved on 
incorporation (Fig. 5e). As these labelled nucleotides diffuse around the polymerase active 
site, they generate a small noise signal. However, when the DNA polymerase encounters 
the nucleotide complementary to the next base in the template, it is incorporated into the 
growing DNA chain, and held in place for orders of magnitude longer than the average 
diffusing nucleotide. This creates a measurable coloured signal that can be differentiated 
from simple diffusion. Following incorporation, the fluorescent label is cleaved (as part of 
the chemistry of forming the phosphate chain) and diffuses away, allowing the DNA 
polymerase to continue to incorporate multiple bases per second. 
 
Ion Torrent (Life Technologies). 
As with other methodologies, the first stage of Ion Torrent sequencing relies on adding 
adapters of known sequence to template dsDNA by ligation or PCR. These adapters are 
used to capture the library clonally onto solid particles, and then to amplify the target 
sequences through emulsion PCR (Fig. 3a–c). The amplified library is then separated, one 
bead per well, on a high-density array (Fig. 4a). These wells sit on top of an ion-sensitive 
semi-conductor. During DNA polymerase-catalysed extension, a hydrogen ion is released 
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as part of the normal chemistry of nucleotide incorporation (Fig. 5c). This ion is detected 
by the semi-conductor as a small change in pH. Like pyrosequencing, which measures 
released PPi, the extent of the change in pH with Ion Torrent sequencing is determined by 
the number of base incorporations, rendering it sensitive to misreading the length of 
homopolymers. 
 
Choice of platform 
Deciding which technology is best is a contentious issue and will ultimately depend on the 
specific experiment being planned. Important factors include the size of the genome being 
considered, its complexity including G+C content, as well as the depth of coverage and 
accuracy required. It is therefore most important to take advice from local service 
providers. That said, some general principles based on current technology performance 
may help to guide the decision-making process. For those looking to assemble complex 
genomes de novo, longer read lengths may be appropriate. For those seeking faster 
turnaround times, then the smaller platforms may offer greater flexibility, depending on the 
size of the laboratory (Loman et al., 2012). 454 sequencing (Roche), whilst currently 
relatively expensive, still has a niche in amplicon sequencing because of its longer reads. 
Other platforms may be more appropriate for direct RNA sequencing (Helicos) and very 
long reads (PacBio). However, as both are single-molecule sequencers, accuracy may 
become an important issue depending on the experiment. In the authors’ experience, the 
Illumina and SOLiD platforms currently offer the best all-round value for money, accuracy 
and throughput for RNA-seq (see section on Transcriptomics), and those projects requiring 
high depths of coverage. 
 
Sample preparation 
The amount of sequence generated by each platform may seem excessive for viral 
genomes that typically range in size from 5 to 350 kb. However, in most cases sequencing 
occurs on a solid platform, whether a glass or microwell plate. These surfaces can be 
readily partitioned to allow several samples to be sequenced independently on a single run 
of the machine. In addition, by the use of distinct adapters that contain unique sequence 
motifs or tags that are also sequenced during the reaction, libraries of different samples 
can be mixed and sequenced together, their sequences being partitioned back to their 
respective samples based on the unique sequence tags in their adapters. This process is 
usually referred to as barcoding. In addition, many of the companies that manufacture the 
platforms discussed above are producing smaller machines with such users in mind. 
One of the crucial features for ultimate sequencing success is how the template nucleic 
acid is prepared. Clearly, the appropriate nucleic acid must be purified, whether it be RNA 
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or DNA. As obligate intracellular organisms, viral preparations are usually heavily 
contaminated by host nucleic acid, and it is wise to remove as much of this as is practical 
in order to ensure as many of the resulting sequence reads of viral rather than host origin. 
For DNA and RNA viruses, the nature of contaminating nucleic acid may vary. In all cases, 
the best starting material contains little other genetic information, such as cerebrospinal 
fluid and serum. However, methods are also described for more cellular material (Daly et 
al., 2011). In many cases, simple viral purification can work; low-speed centrifugation to 
remove cellular debris, followed by high-speed sedimentation to concentrate packaged 
viral genomes. RNase and/or DNase treatment can be used to remove unpackaged and 
unprotected contaminating nucleic acids. In other cases, more specific purification may be 
followed based on density gradients. Where the goal is to sequence one or just a small 
number of genomes, crude purification is often sufficient, especially where the academic 
value of the genomes is high. Under these circumstances, only a small percentage (1% or 
less) of the reads would typically be of viral origin. If the goal is to sequence many 
hundreds of genomes, and where it is important to achieve full genome coverage, then 
simple methods of prior virus enrichment, including PCR, are needed. More recently, 
hybridization capture has been used to enrich viral nucleic acid prior to deep sequencing, 
allowing whole herpesvirus genomes to be sequenced from clinical samples (Depledge et 
al., 2011). In each experiment, there is a clear trade-off between sample purity and 
time/cost for purification, and each project needs assessment on its own values. 
 
Bioinformatics 
The informatics requirements of NGS projects are ignored at the researcher’s peril. 
Arguably, it is easy to now generate many million bases of sequence; the challenge can be 
to use it efficiently. A full discussion of informatics is beyond the scope of this article. 
However, key processes in the pipeline are quality scoring, sequence assembly and 
annotation. Manipulating typical output files, including both individual reads and their 
alignments into continuous sequences (contigs), can be challenging due to their size. 
Post-sequencing, there are two approaches that can be used in analysis of read data. If a 
reference genome is available, then the sequences can be mapped directly to this 
reference using a mapper such as BWA (Li & Durbin, 2009). This provides rapid information 
about substitutions, insertions, deletions and gene loss, but is not applicable if the aim of 
the research is to look for novel genes or sequence. Under these circumstances, or where 
a suitable reference genome is not available, individual sequencing reads can be 
assembled de novo using other software such as Velvet (Zerbino & Birney, 2008) or MIRA 
(Chevreux et al., 1999), which use algorithms to find overlapping information between 
reads, leading to the generation of contigs. This approach allows discovery of novel genes 
and sequences, as well as small variants (e.g. SNPs and indels). 
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Both the de novo and mapping strategies may not cover the entire genome, due either to 
insufficient depth of coverage or to genomic repeats that, if the read length is smaller than 
the repeat, cause gaps in the genome assembly. The size of these gaps can be 
approximated by comparison with a reference genome or, alternatively, may be crossed 
using paired-end (or mate-paired) libraries. Here, larger fragments of DNA are first purified 
(e.g. 2–8 kb), adapters are added on either end and the molecule is circularized. This 
brings two regions of the genome, previously separated by several thousands of bases, 
into close contact, separated by the adapters. These circular DNA molecules are 
fragmented and sequenced in the usual way. This not only allows the original ends of the 
molecule to be sequenced, but crucially also identifies their relative position and 
separation in the genome. Sequence from paired-end libraries can be built informatically 
into genome ‘scaffolds’, showing the order and relative positions of individual contigs, 
thereby facilitating genome closure. Genome gaps can be closed by conventional PCR 
followed by more traditional Sanger sequencing; whether this is necessary depends on the 
nature of the project. 
 
Utilities in virology 
 
Genome sequencing 
Perhaps the most obvious application of these technologies is genome sequencing. 
Although viral genomes are relatively small, their academic value is often extremely high, 
and, when coupled with barcoding and partitioning, NGS can represent a highly efficient 
way of sequencing full viral genomes. It is impractical to provide an exhaustive list of the 
viral genomes published by NGS, and any such list would rapidly go out of date. Rather, 
we provide two examples of this approach, chosen from extremes of the viral landscape, 
namely Marseillevirus, a DNA virus with one of the largest viral genomes known, and 
influenza virus, a small, segmented RNA virus. 
Marseillevirus belongs to the nucleocytoplasmic large DNA viruses (NCLDVs), which 
includes poxviruses, asfarviruses, iridoviruses, phycodnaviruses and mimiviruses – the 
biggest type of virus. The genome was a circular dsDNA molecule of 368454 bp (Boyer et 
al., 2009). Despite its size, the whole genome sequence was achieved in a single 
experiment (F. Ghislain, personal communication). In total, 457 ORFs were predicted to 
encode proteins ranging from 50 to 1537 aa. The coding sequences represented 89% of 
the genome. The genome repertoire of the virus was composed of typical NCLDV core 
genes, as well as genes apparently obtained from eukaryotic hosts and their parasites or 
symbionts, both bacterial and viral. This study led the authors to propose that amoebae 
are ‘melting pots’ of microbial evolution where diverse forms emerge, including giant 
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viruses with complex gene repertoires of various origins. A powerful way to compare family 
members of large genomes is by comparing the ancestral gene set, i.e. the proportion of a 
genome’s coding capacity that is conserved with other members of the family. Of the 41 
NCLDV genes previously identified as comprising the ancestral gene set of the NCLDV 
(e.g. replication machinery, RNA polymerase subunits, transcription factors, capping and 
polyadenylation enzymes, DNA-packaging apparatus and structural components of an 
icosahedral capsid and the viral membrane), only 28 were identified in the Marseillevirus 
genome, suggesting that whilst Marseillevirus is likely to be a true NCLDV, it is related 
somewhat distantly to other known virus families. 
Almost at the extreme other end of viral biodiversity from Marseillevirus are the influenza 
viruses, with relatively small, segmented RNA genomes. The need for genome sequencing 
of these viruses has been driven by the emergence of H5N1 (Höper et al., 2009) and an 
H1N1 pandemic, with an urgent need to understand the evolution and molecular 
epidemiology of these viruses. Added sequencing complexity comes from a segmented 
genome and associated recombination events, meaning that phylogenetic analyses based 
on partial sequence information can never pick up the full complexity of historical 
recombination events that often lead to pandemic emergence. Clearly, full genome 
sequences can be obtained from clinical material by segment-specific PCR and more 
traditional Sanger sequencing (Smith et al., 2009; Vijaykrishna et al., 2011). However, 
more recently, methods have been described based on pooling of segment-specific PCRs 
obtained directly from clinical material (Höper et al., 2009, 2011) or following purification of 
virus particles from cell culture (Lorusso et al., 2011), followed in both cases by tagging 
and sequencing. By allowing many full genomes to be sequenced, NGS has effectively 
removed a major bottleneck to our understanding of the emergence and transmission of 
these important viruses (Baillie et al., 2012). The remaining challenge is to reduce the time 
for sequence production to a point where sequence information can be used routinely in 
real time to aid health protection agencies in the control of outbreaks. 
In the authors’ laboratories, we have now used NGS platforms to obtain de novo sequence 
from multiple virus families, including Poxviridae, Parvoviridae, Picornaviridae, 
Herpesviridae, Asfarviridae (Chapman et al., 2011) and Rhabdoviridae, underlying the 
broad applicability of these techniques to this field of virology. Cleary, single full genome 
sequences are incredibly valuable to understanding virus biology, but perhaps of more 
interest is the ability that NGS provides to sequence and compare multiple full genomes of 
distinct types, to identify important genetic differences between them (Szpara et al., 2010). 
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Targeted amplification of virus to look at resistance profiles to drugs and host 
immunity 
One of the striking features of viral genomes is their potential for high evolution rates, a 
feature of short generation times and, for RNA viruses in particular, low-fidelity 
polymerases. This has for many years been enshrined in the concept of the viral 
quasispecies, whereby many RNA viruses are believed to exist at the sample level, not as 
a single sequence but as a collection of closely related variants (Lauring & Andino, 2010). 
This diversity creates a challenge for those wishing to sequence viruses, such that many 
of the sequences for RNA viruses, particularly those based on PCR without cloning, 
represent average, majority or consensus sequences for these populations. Generally, 
minority members of the population are ignored, which in most cases is entirely acceptable 
practice. However, in evolutionary terms, this existing diversity represents a massive 
reserve on which selection can occur and from which fitter variants can emerge rapidly. 
These are of concern not only for immune escape, but also in antiviral chemotherapy, 
where minor population variants harbouring resistance mutations can be rapidly selected 
for, leading to failure of antiviral therapy. This has led the WHO to establish a global 
strategy for the prevention and assessment of human immunodeficiency virus (HIV) drug 
resistance and, amongst its many roles, the Global Influenza Surveillance and Response 
System has been closely monitoring the evolution of influenza viruses infecting humans, 
including their susceptibility to antiviral drugs. 
There is a long history of attempts to characterize the viral quasispecies and to identify 
clinically significant minor variants within it. Generally, this has been done by PCR 
amplification and direct sequencing, which may only be able to detect mutations that exist 
at 10–20% frequency in the population (Varghese et al., 2009; Wang et al., 2007), or line 
probe assays, which, although perhaps slightly more sensitive, can only detect known 
mutations (Lok et al., 2007). Sensitivity can be increased by using limiting-dilution PCR, 
i.e. essentially sequencing multiple individual molecules from each sample; however, this 
clearly comes at a considerable cost (Palmer et al., 2005; Wang et al., 2007). In 
comparison, it is generally accepted that NGS of amplicons can detect minority variants 
present in 1–2% of sequence reads (Varghese et al., 2009), and it is now accepted that 
NGS detects many more minority mutations than more traditional methods (Margeridon-
Thermet et al., 2009). For example, in one study of HIV population mutations, ultradeep 
pyrosequencing detected on average seven times more variants than conventional 
methods, with all variants present in 3% of genomes and 57% of variants present in 3% 
of genomes confirmed by limiting-dilution sequencing (Wang et al., 2007). The limitation to 
this detection threshold is driven both by error rates of the polymerases used and by 
pyrosequencing errors around homopolymers, and has been estimated by amplifying 
plasmid sequences (Margeridon-Thermet et al., 2009; Mitsuya et al., 2008; Solmone et al., 
2009; Varghese et al., 2009; Wang et al., 2007). To the authors’ knowledge, error rates 
associated with reverse transcription have not been included, so this represents an 
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important area for future research, particularly as direct RNA sequencing becomes 
available (Ozsolak et al., 2009). 
NGS has predominantly been used to monitor population diversity in HIV (Eriksson et al., 
2008; Hoffmann et al., 2007; Ji et al., 2010; Wang et al., 2007) and hepatitis B virus (Homs 
et al., 2011; Margeridon-Thermet et al., 2009; Solmone et al., 2009), but it is now starting 
to be used for other viruses (Geret et al., 2011; Görzer et al., 2010; Hiraga et al., 2011; 
Tapparel et al., 2011; Verbinnen et al., 2010; Wellehan et al., 2010). The methodology is 
starting to shed new light on other areas of viral pathogenesis where minor population 
variants may also be highly significant. These include assays for receptor usage 
(Raymond et al., 2011) and minor pathogenic variants (Geret et al., 2011), and studies to 
understand immune escape in simian immunodeficiency virus (Bimber et al., 2009; 
Hughes et al., 2010). Studies using NGS to dissect the dynamics of transmission have 
shed new light on the differences between resistance acquired by transmission and that 
which has evolved within the patient (Varghese et al., 2009). In addition, some studies are 
now moving away from sequencing of specific genomic regions to estimating the diversity 
across the whole genome (Bimber et al., 2010; Tapparel et al., 2011; Willerth et al., 2010). 
Such an approach is likely to generate new insights into the roles of previously 
understudied viral genes in pathogenesis. The use of barcoding and multiplexing provides 
opportunities to increase the cost-effectiveness of this approach (Hoffmann et al., 2007; Ji 
et al., 2010). 
 
Viral metagenomics 
Metagenomics can be defined as the characterization of genetic information directly from 
samples. It has the benefit of not requiring previous culture, making it particularly attractive 
when trying to characterize the ‘viral metagenome’ or ‘virome’. The term ‘metagenome’ 
first appeared in PubMed in 1998 (Handelsman et al., 1998) in relation to classifying 
unculturable bacteria from soil, when such early studies relied on the use of random 
bacterial cloning and sequencing (Breitbart et al., 2003). The availability of NGS has 
allowed these metagenomes to be analysed in unbiased ways at previously unseen 
resolution, and is providing a wealth of new opportunities in two major areas: viral 
candidate pathogen discovery and viral ecology. 
 
Virus candidate pathogen discovery. 
The threat of newly emerging viruses to important species remains ever-present. In 
humans, although viruses currently make up a small proportion of known human diseases, 
they make up the majority of newly identified ones (Woolhouse & Gaunt, 2007). The rate 
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of discovery of new virus infections has remained largely unchanged over many decades 
and suggests that many new viruses remain to be discovered (Woolhouse et al., 2008). 
In the face of new outbreaks of a disease, there is an imperative to rapidly characterize the 
infectious agent to understand better the disease, and to allow the development of specific 
diagnostic tests and control measures. Ideal methods are non-specific and have included 
electron microscopy, virus isolation, cloning, degenerate or consensus PCR, 
representational difference analysis (RDA) and sequence-independent single primer 
amplification (SISPA) (Ambrose & Clewley, 2006; Bexfield & Kellam, 2011; Tang & Chiu, 
2010). The most high-profile recent example of this was the SARS (severe acute 
respiratory syndrome) coronavirus. The new respiratory syndrome was first reported by 
the World Health Organization (WHO) on 14 March 2003(Anonymous, 2003). Initially, 
large-scale screens for known pathogens were carried out to try to identify a common 
factor in cases using virus isolation, electron microscopy, PCR and antigen-based 
methods (Drosten et al., 2003). Several ‘red herrings’ were identified, most notably a 
paramyxovirus. Ultimately, random PCR (Drosten et al., 2003) or degenerative coronavirus 
primers (Ksiazek et al., 2003) amplified the first SARS coronavirus sequences, which were 
published electronically in the New England Journal of Medicine on 10 April 2003. On 5 
July 2003, the WHO declared the SARS outbreak contained 
(http://www.who.int/mediacentre/news/releases/2003/pr56/en/). 
Whilst the SARS story represented a considerable triumph in global cooperation and 
pathogen discovery, with only approximately 1 month between syndrome description and 
pathogen discovery, it is highly likely that any such future discovery projects would be 
carried out by NGS in a fraction of the time, and here we describe just one of many 
examples that shows the speed of such approaches. In 2008, an outbreak of unexplained 
haemorrhagic fever in people was reported in South Africa. The index patient was 
admitted to a clinic on 12 September 2008. Over the following 2 weeks, secondary and 
tertiary cases were reported, with four of the five patients dying. Such outbreaks of 
haemorrhagic fever are highly emotive events, necessitating a rapid response to control 
both infection and public anxiety. RNA extracts from two post-mortem liver biopsies (cases 
2 and 3) and one serum sample (case 2) were submitted to NGS. BLAST analysis of the 
resulting sequences identified contigs corresponding to about half of the approximately 10 
kb genome of a novel arenavirus (Briese et al., 2009). The majority of sequences were 
obtained from serum rather than tissue, presumably reflecting the higher levels of host 
DNA obtained from the highly cellular tissue samples. 
Such rapid results are highly significant for several reasons. As the method used is not 
predicated on sequence-specific amplification, it has a high probability of success, 
providing that sufficient sequencing is done. Indeed, for influenza virus it has been shown 
that NGS has sensitivity on clinical specimens close to that of specific PCR (Greninger et 
al., 2010). Secondly, rapid pathogen discovery is now accessible to all outbreaks, 
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regardless of the profile of the disease, as reported recently for Schmallenberg virus of 
ruminants (Hoffmann et al., 2012). Thirdly, it works very quickly, allowing authors to obtain 
a candidate diagnosis in only 72 h. Finally, when used in novel samples, it often finds a 
wealth of previously unrecognized viruses (Day et al., 2010). 
This last point highlights a key issue: clearly, the identification of viral sequences in clinical 
material is far from showing an association with disease (Lipkin, 2009). In some cases, 
small case–control studies have sought to compare metagenomes in health and disease, 
including in cystic fibrosis (Willner et al., 2009) and chronic fatigue syndrome (Sullivan et 
al., 2011), to try to determine the significance of any one genome to disease. However, 
cost will currently limit such an approach to those diseases where a single pathogen is 
perhaps unlikely. More typically, traditional methods will be employed to seek proof of an 
association between any newly discovered virus and disease. These methods include 
classical infection studies to achieve Koch’s postulates, larger case–control studies using 
traditional diagnostics methods such as PCR to compare the prevalence of the new viral 
sequences in health and disease, or the detection of acquired immunity showing a 
temporal association between infection and disease. Even when all this is done, it is likely 
that NGS technologies will lead to the identification of an expanding class of viruses that 
historically would have been called ‘orphan’ viruses, viruses in search of a disease, and 
commensals (Dolgin, 2011). The latter represents an exciting area of research. For 
obvious reasons, much of virology has historically been driven by those viruses 
responsible for disease. Technologies such as NGS may now allow us to open a window 
on the role of viruses in our health. 
 
Environmental viral metagenomics. 
Moving away from pathogen discovery in clinical samples, NGS is being used increasingly 
to explore the viral diversity in a wide range of environmental samples, shedding new light 
on what might be considered normal. 
Recent examples where this technology is being applied include faeces (Donaldson et al., 
2010; Li et al., 2010; Reyes et al., 2010), sewage (Cantalupo et al., 2011), vaccines 
(Victoria et al., 2010), plants (notably grapevines) (Coetzee et al., 2010) and 
environmental samples including water (López-Bueno et al., 2009; Rodriguez-Brito et al., 
2010). A recent paper has described the use of blood-feeding mosquitos as a way of 
sampling a broad range of viral diversity (vector-enabled metagenomics) and of identifying 
a broad range of animal, plant, insect and bacterial viruses (Ng et al., 2011). 
A review of ocean viromes suggests that the sea is dominated by rare genes, many of 
which might be contained within virus-like entities such as gene-transfer agents 
(Kristensen et al., 2010). The same study predicted a wealth of DNA viruses belonging to 
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the eukaryotic NCLDVs, and suggested that the RNA virome was dominated by picorna-
like viruses. 
Although virus candidate pathogen discovery and environmental viral metagenomics can 
be broadly thought of as separate disciplines, they are highly related, as they both 
essentially seek to identify correlations between virus populations and sample phenotype. 
Recurring themes often include using samples low in contaminating host nucleic acid, 
such as faeces (Victoria et al., 2009) or serum (Towner et al., 2008), filtration of samples 
to remove contaminating genetic material, and sequence-independent reverse 
transcription and PCR amplification of capsid-protected, nuclease-resistant viral nucleic 
acids. As the wide range of undiscovered viral diversity can now begin to be illuminated, 
an important challenge is how to identify truly novel sequences when comparing newly 
generated sequence to published databases. Several approaches have been developed to 
facilitate this, including searching based on amino acid similarity and by the recreation of 
theoretical ancestral sequences (Delwart, 2007). As with other molecular methods, the 
sensitivity of NGS, which can detect rare viral transcripts at frequencies lower than 1 in 
1000000 (Moore et al., 2011), does bring with it considerable potential for sample 
contamination (Schmieder & Edwards, 2011). 
 
Transcriptomics 
Whilst genomic data are clearly extremely valuable in their own right, other areas of 
science are turning increasingly to the transcriptome, the measurement of mRNA, to 
achieve new insights into genome expression and how this may be modified in health and 
disease. Historically, oligonucleotide microarrays have been used to quantify gene 
expression throughout biology, but now these approaches are largely being replaced by 
NGS of transcribed RNA – so called RNA-seq (Marioni et al., 2008; Wilhelm & Landry, 
2009). 
Key steps in the process firstly include isolation of RNA and removal of host genomic 
DNA. Subsequently, rRNA is also removed by selection of polyadenylated RNA or removal 
of rRNA with antisense oligos. Complementary DNA synthesis is primed either by 
oligo(dT) or randomly. On long transcripts, the former can lead to bias sequencing of the 3′ 
end and failure to determine the transcript start site. Strand specificity of transcription is 
lost in routine preparation of double-stranded cDNA. However, it can be maintained either 
by adding different adapters to the 5′ and 3′ ends of the RNA transcript, or by marking one 
strand for degradation by chemical modification (Levin et al., 2010). Analysis of RNA-seq 
data is usually achieved by mapping sequence reads to a reference genome, using 
software that can map reads over gene splice junctions (Trapnell et al., 2009). Statistical 
analysis of the number of reads per genome region (gene) can be used to quantify relative 
levels of expression (Anders & Huber, 2010; Robinson et al., 2010). 
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Whilst the use of these technologies is still in its infancy in virology, they are beginning to 
provide new insight on genome coding capacity and biology of transcription, particularly for 
large DNA viruses. For example, in mimiviruses, RNA-seq has identified a new role for 
palindromic sequences in transcription termination (Byrne et al., 2009), confirmed that all 
predicted ORFs are transcribed, as well as identifying new ORFs (Legendre et al., 2010, 
2011). In poxviruses, RNA-seq has been used to revisit temporal trends in gene 
expression (Yang et al., 2011b), to identify interactions between the host and poxviral 
transcriptome (Yang et al., 2010) and to map transcription start and stop sites precisely 
(Yang et al., 2011a). In herpesviruses, new insight has been made into the role of viral 
gene expression in Epstein–Barr virus latency (Lin et al., 2010), and in cytomegalovirus, 
the significance of non-coding transcripts and splice variants has been characterized, as 
well as identifying new protein-coding transcripts (Gatherer et al., 2011). The technology is 
clearly not limited to large DNA viruses, and has also been used to identify differences in 
expression and post-transcriptional modification associated with lentivirus virulence (Ertl et 
al., 2011). 
NGS also provides a new way to explore the role of microRNAs in virus replication and 
pathogenesis. These short RNA molecules of about 21–22 bases in length function as 
negative regulators of mRNA translation (Sayed & Abdellatif, 2011) and their role is now 
being explored in several viral systems, including latency in herpes simplex virus (Umbach 
et al., 2008) and Epstein–Barr virus (Riley et al., 2012), cytomegalovirus (Stark et al., 
2012), transformation in Marek’s disease virus (Burnside et al., 2006) and Kaposi’s 
sarcoma-associated herpesvirus (Wu et al., 2011), and grapevine pathology (Pantaleo et 
al., 2010). 
Of course, there are two sides to a transcriptome for viruses, namely that of the virus and 
its host. Virus-induced perturbations to the host transcriptome are clearly of critical 
importance to infection outcome. However, methodological limitations have meant that, 
until recently, the study of pathogenesis has been heavily driven by targeted analysis of 
specific genes or pathways thought to be critical to disease progression. Although this 
review has concentrated on the use of NGS to study viral sequences directly, it is clear 
that these approaches provide new opportunities to explore the interaction of replicating 
viruses with their host, particularly their transcriptome, in a non-targeted, hypothesis-
generating mode. Recent examples include gene profiling of early and advanced liver 
disease in chronic hepatitis C virus (HCV)-infected patients (Khalid et al., 2011), the 
replication of HCV in vitro (Woodhouse et al., 2010), host gene shut-off in Kaposi’s 
sarcoma-associated herpesvirus, and the identification of host transcripts refractory to 
shut-off (Clyde & Glaunsinger, 2011). 
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The future 
Despite the rapid progress that has been made in these technologies over the last 5 years, 
new developments are still likely. In the last year, there has been a lot of publicity around 
single-molecule nanopore technologies that aim to allow simple, cheap, single-molecule 
DNA sequencing in devices no larger than a smartphone (Eisenstein, 2012). These 
technologies work by pulling DNA through tiny pores and reading the bases as they pass 
through as changes in electric current across the pore. This process could remove the 
need for enzymic processes and imaging completely and could potentially generate very 
long reads very rapidly. Whilst no substantial data have yet been seen, this method could 
become available in 2013. If the technology delivers, then devices could be available in 
clinics very rapidly afterward, becoming a key technology in diagnostic medicine. 
As all of the available sequencing chemistries are becoming established and maturing, 
read lengths and fidelity should increase, allowing us to explore deeper into viral genome 
diversity. All of the major platforms are being developed to be easier to use and more cost-
effective, and some of the major companies have now released cheaper benchtop 
machines, with the aim of democratizing this technology and making it more readily 
available (Loman et al., 2012). The ultimate consequence of such democratization will be 
to bring NGS sequencing into many more research laboratories, as well as routine 
diagnostics for human, animal and plant disease, thereby providing new insights into the 
complex virome in which we all live. In medicine, routine sequencing of the human 
genome will herald new opportunities for personalized medicine. It perhaps follows that 
similar opportunities allowing antiviral therapy to be better-matched to individual genome 
sequences will exist, as already happens to some extent for HIV. 
Improvements in the area of sample preparation have been rapid, including recent 
developments in genome partitioning (also known as enrichment). This allows targeting of 
a specific region, sets of genes or indeed entire exomes. Technology platforms include 
either microarrays on solid substrates, free RNA or DNA oligos that can be separated from 
other fragments using biotin tags, or high-throughput PCR-based techniques (reviewed by 
Mamanova et al., 2010). Such approaches may be particularly appropriate for viruses as a 
way of removing contaminating host DNA. 
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Fig. 1. Scale of sequencing information available in GenBank. (a) Percentage growth of 
sequences deposited on GenBank between August 2009 and August 2010. Sequences 
are grouped based on the GenBank classification of division, either by their higher 
taxonomy or the sequencing method employed (Benson et al., 2011). (b) The 20 most 
frequently sequenced viruses appearing on GenBank. Sequences were identified based 
on their organism name as described in each submission; PRRSV, porcine reproductive 
and respiratory syndrome virus. These data were compiled using EID2 (Anonymous, 2012). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Preparation of DNA. (a) Double-stranded template DNA is (b) randomly degraded, 
size-fractionated and ligated to adapters. (c) Alternatively, targeted amplification of the 
template can also be carried out by PCR.  
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Fig. 3. General principles of template amplification. (a–c) Emulsion PCR (Roche 454, 
SOLiD and Ion Torrent). (a) Adapters are used to capture single molecules of template 
onto microbeads by primer hybridization. (b) Beads are incorporated into a carefully 
controlled emulsion, in which each bubble constitutes a microreactor containing DNA 
template, primer and reagents for PCR. (c) Following amplification, each bead is coated 
with clonally amplified molecules. (d–h) Bridge amplification (Illumina). (d) Single-stranded 
template annealed to a glass plate by hybridization to a complementary primer. (e) The 
primer forms the basis for extension. (f) The free end of each single-stranded molecule 
can anneal to a second anchored primer in close spatial proximity, forming a ‘bridge’ that 
acts as a template for (g) a second round of amplification. This results in (h) four linear 
molecules. Stages (f)–(h) are essentially repeated to generate clonally amplified islands or 
clusters for subsequent sequencing. (i–m) Linear amplification (PacBio). (i) Template 
dsDNA. (j) Bound hairpin adapters create a single-stranded circular template. (k) Binding 
of a primer complementary to hairpin sequence. (l–m) Linear amplification and strand 
displacement create a single strand of DNA containing multiple copies of plus- and minus-
strand sequences that serves as template for sequencing.  
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Fig. 4. Methods of separating sequencing reactions. (a) Microbeads (Roche 454) or Ion 
Spheres (Ion Torrent) in microwells. (b) Clonally amplified beads bound to glass plate 
(SOLiD). (c) Amplified islands (Illumina). (d) Poly(A)-tagged library hybridized to plate 
(Helicos). (e) Amplified molecule captured by a single DNA polymerase molecule at the 
bottom of a microcell (PacBio). 
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Fig. 5. Basic principles of sequencing chemistry. (a) Normal chain elongation leads to the 
release of (b) a hydrogen ion (Ion Torrent) and (c) pyrophosphate (Roche 454). (d) 
Structure of the ddNTP that forms the basis of Sanger sequencing. (e) Cartoon of the 
phospholinked fluorophore (PacBio). (f) Sequencing by ligation (SOLiD – see Fig. 6). (g) 
Cartoon of reversible chain terminators (Illumina and Helicos). 
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Fig. 6. Basic principles underlying sequencing by ligation (synthesis) used by SOLiD. 
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Table 1. Summary of current next-generation technologies: methods used in sample preparation, molecule separation and sequencing, 
and advertised outputs 
First step for all methods is template fragmentation. 
Method Adapter type Amplification? Separation Sequencing chemistry Approximate 
read length 
(bases)† 
Approximate 
maximum amount 
of data per run† 
Roche 454* Adapters Emulsion PCR Microbeads and ‘picotitre’ plate Pyrosequencing 400–700 700 Mb 
SOLiD Adapters Emulsion PCR Beads on glass slide Ligation 50–75 20 Gb 
Illumina* Adapters Bridge amplification 
in situ 
Glass slide hybridization Reversible terminators 25–500 600 Gb 
Helicos Poly(A) adapter No amplification Flow-cell hybridization Reversible terminators 25–55 35 Gb 
PacBio Hairpin 
adapters 
Linear amplification Captured by DNA polymerase 
in microcell 
Fluorescently labelled dNTPs 1000 Not available 
Ion Torrent* Adapters Emulsion PCR Ion Spheres and high-density 
array 
Detection of released H+ 35–400 1 Gb 
*These technologies are available on platforms with different scales of throughput (Loman et al., 2012). 
†Approximate values based on data published on the companies’ websites on 9 March 2012. These data are for guidance only and are subject to change; readers 
interested in the details should consult either the manufacturers or those that are offering the sequencing service. 
